Notably, the Pathways in Cancer signature also incorporates PI3K-AKT signaling whose regulatory state correlated with the cell phenotypes observed, and whose broad contributions in conferring malignant characteristics has prioritized it as a target in breast and other cancer types 63. This evidence concerns the gene AKT1 and cancer.